Connect with us
Able has designed a robotic exoskeleton for people with disabilities. In Germany, Able's CEO highlights the fact that the company has carried out part of the...
The company, founded in 2015, although the project started in 2017, raised $601,000 (€600,000)in January 2021 to start the process of clinical validation of its device....
Moderna is now advancing two bivalent candidates for fall, based on differing market preferences for Omicron subvariants. The bivalent booster mRNA-1273.214 is the only candidate that...
Efpia's report highlights that in 2021 China almost equaled Europe as the region where new drugs were discovered and launched, with 18 and 19 new drugs,...
With the capital raised, Nimble will complete the preclinical testing phase, incorporate regulation and hire personnel. In addition, the company intends to test its tool within...
 |
|
 |  |
 |
|